Discover 1,461 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,461
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
for
Heavy Menstrual Bleeding, Bleeding Disorder,
Location: Seattle WA, Portland OR, Palo Alto CA, Aurora CO,
Sponsor: Oregon Health and Science University
Sex: Female
Age: 10 - 24
Code: NCT05916469
Recruiting
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
for
Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis),
Location: Seattle WA
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0 - 55
Code: NCT07791862
Recruiting
REACT-01: Reversing Autoimmunity Through Cell Therapy
for
Systemic Lupus Erythematosus
Location: Seattle WA
Sponsor: Seattle Children's Hospital
Sex: All
Age: 2 - 30
Code: NCT06465147
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Olympia WA, Portland OR, Spokane WA, Reno NV,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05947851
Phase 3, Recruiting
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Olympia WA, Portland OR, Eugene OR, Edmonton, Reno NV,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase 3, Recruiting
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
for
Cancer, Medication Adherence
Location: Seattle WA, Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 15 - 24
Code: NCT07223463
Recruiting
Pediatric Lumbar Puncture Success Using the COMPASS
for
Lumbar Puncture
Location: Seattle WA
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0 - 18
Code: NCT01285531
Recruiting
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma,
Location: Seattle WA, Chicago IL, Houston TX, Ann Arbor MI,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 1 - 39
Code: NCT05843253
Phase 2, Recruiting
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
for
Type 2 Diabetes Mellitus, Diabetic Kidney Disease,
Location: Seattle WA, Aurora CO
Sponsor: Petter Bjornstad
Sex: All
Age: 8 - 14
Code: NCT05008276
Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
for
Acne
Location: Seattle WA, Missoula MT, Edmonton, Santa Rosa CA,
Sponsor: Sanofi Pasteur, a Sanofi Company
Sex: All
Age: 18 - 45
Code: NCT06316297
Phase 1, Phase 2, Recruiting
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion